# NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission

> **NCT00089505** · PHASE3 · COMPLETED · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 745 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Emtricitabine
- **DRUG:** Emtricitabine/Tenofovir disoproxil fumarate
- **DRUG:** Lopinavir/Ritonavir
- **DRUG:** Nevirapine
- **DRUG:** Tenofovir disoproxil fumarate

## Key facts

- **NCT ID:** NCT00089505
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2010-08
- **Final completion:** 2011-02
- **Target enrollment:** 745 (ACTUAL)
- **Last updated:** 2018-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00089505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00089505, "NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00089505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*